Translations:Sulfonylurea/8/en: Difference between revisions

From Azupedia
Jump to navigation Jump to search
VisualWikitext
FuzzyBot (talk | contribs)
15,166 edits
Importing a new version from external source
 
(No difference)

Latest revision as of 20:35, 12 March 2024

Information about message (contribute)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (Sulfonylurea)
A 2011 [[Cochrane (organisation)|Cochrane]] [[systematic review]] evaluated the effects on treatment of [[Latent autoimmune diabetes in adults|Latent Autoimmune Diabetes in Adults]] (LADA) and found that Sulfonylureas did not improve metabolic control of [[glucose]] at 3 and 12 months, even worsening [[Glycated hemoglobin|HbA1c]] levels in some cases, when compared to insulin. The same review did not find improvement of fasting C-peptide following treatment with sulfonylurea. Still, it is important to highlight that the studies available to be included in this review presented considerable flaws in quality and design.

A 2011 Cochrane systematic review evaluated the effects on treatment of Latent Autoimmune Diabetes in Adults (LADA) and found that Sulfonylureas did not improve metabolic control of glucose at 3 and 12 months, even worsening HbA1c levels in some cases, when compared to insulin. The same review did not find improvement of fasting C-peptide following treatment with sulfonylurea. Still, it is important to highlight that the studies available to be included in this review presented considerable flaws in quality and design.

Retrieved from "https://wiki.tiffa.net/w/index.php?title=Translations:Sulfonylurea/8/en&oldid=128388"